Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seragon names Tony Coles to board

This article was originally published in Scrip

Executive Summary

San Diego-based Seragon Pharmaceuticals, a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, has named N Anthony (Tony) Coles to its board of directors. Most recently, Dr Coles was president, chief executive officer and chair of the board of Onyx Pharmaceuticals, a global biopharmaceutical company acquired by Amgen in October 2013. He is currently a member of the board of directors of McKesson Corporation, vice-chair of the board of trustees for Johns Hopkins University, and a member of the board of trustees for Johns Hopkins Medicine.  Dr Coles is also a member of the board of the US Olympic and Paralympic Foundation.

Advertisement
Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC024872

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel